GASTRIC CANCER (GC)

This study tests a combination of three drugs (sintilimab, bevacizumab, and chemotherapy) in 46 people with a rare, aggressive type of stomach cancer that makes a protein called AFP. The goal is to shrink tumors enough to allow surgery. The study is for people whose cancer has no…

This study is for people with advanced HER2-negative stomach or gastroesophageal junction cancer that cannot be removed by surgery. It tests a new approach: giving a special type of radiotherapy followed by a combination of two immunotherapy drugs (iparomlimab and tuvonralimab) p…

This early-phase study tests a new cell therapy called NK510 in 15 people with advanced stomach or colon cancer that has not responded to standard treatments. The therapy is given through an IV or directly into the belly to see if it is safe and can shrink tumors. The goal is to …

This study compares two types of minimally invasive surgery for people with a certain stage of stomach cancer (cT4a). Participants will be randomly assigned to have their tumor removed by either a robot-assisted or a standard laparoscopic procedure. The main goal is to see if the…

This study tests a new drug called QLS5132, given with other cancer treatments, for people with advanced solid tumors like stomach, lung, ovarian, or endometrial cancer. The goal is to find safe doses and see if the combination shrinks tumors. About 626 participants will receive …

This study tests a new drug, JPI-547, combined with the chemotherapy irinotecan for people with advanced stomach cancer that has come back or spread. It is for patients who have already tried at least two other treatments. The goal is to see if the combination is safe and can shr…

This study explores a new way to diagnose gastric cancer by detecting tiny particles called extracellular vesicles in stomach fluid using a special sensor. Researchers will collect stomach fluid from 100 patients undergoing endoscopy and analyze it with surface plasmon resonance …

This study tests a new type of PET scan that uses a special probe to find cancers that have a protein called GPA33. The study will include 56 people with suspected or confirmed colorectal, stomach, or pancreatic cancer, as well as healthy volunteers. The goal is to see if this im…

This study looks at whether tumor DNA found in blood or belly fluid can predict if stomach, colon, or pancreatic cancer will spread to the lining of the abdomen (peritoneum). Researchers will follow 300 people with early-stage cancers to see if those with positive DNA tests have …

This study tests whether a special ultrasound can predict if chemotherapy is working for stomach cancer that has spread to the liver. Currently, doctors wait about 2 months for CT or MRI scans to see if tumors shrink. This new ultrasound looks at blood flow inside liver tumors af…

This study aims to develop an artificial intelligence (AI) system that can predict how well stomach cancer will respond to chemotherapy and immunotherapy given before surgery. Researchers will collect data from 2,000 patients with locally advanced gastric cancer and use their CT …